Vetter, a specialist in the aseptic filling of injection systems, opened a new 24,000-ft2 facility in Chicago to manufacture preclinical, Phase I and Phase II clinical batches. The expansions, part of the new Vetter Develoment Services USA Inc., complement the company’s commercial-scale capabilities in Germany. PharmTech Europe Editor Fedra Pavlou, interviewed Peter Soelkner, managing director of Vetter Pharma International GmbH live from the AAPS 2009 show floor in Los Angeles last month. Listen to the podcast here.
See background article, “Vetter Expands Clinical- and Commercial-Scale Operations” by Patricia Van Arnum.